Last reviewed · How we verify
A Study of JNJ-61393215 in Healthy Japanese Male Participants
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) after single dose administrations of JNJ-61393215 in Japanese healthy adult male participants.
Details
| Lead sponsor | Janssen Pharmaceutical K.K. |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | Fri Jan 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy
Interventions
- JNJ-61393215
- Placebo
Countries
Japan